Polar Asset Management Partners Inc. Acquires 417,549 Shares of Envista Holdings Co. (NYSE:NVST)

Polar Asset Management Partners Inc. increased its position in shares of Envista Holdings Co. (NYSE:NVST - Free Report) by 27.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,914,799 shares of the company's stock after purchasing an additional 417,549 shares during the quarter. Polar Asset Management Partners Inc. owned 1.11% of Envista worth $36,936,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in NVST. Thurston Springer Miller Herd & Titak Inc. bought a new stake in Envista in the fourth quarter valued at $53,000. Profit Investment Management LLC increased its stake in Envista by 6.0% during the 4th quarter. Profit Investment Management LLC now owns 127,597 shares of the company's stock valued at $2,461,000 after buying an additional 7,226 shares during the period. Hedges Asset Management LLC increased its stake in Envista by 13.9% during the 4th quarter. Hedges Asset Management LLC now owns 53,300 shares of the company's stock valued at $1,028,000 after buying an additional 6,500 shares during the period. KBC Group NV increased its stake in Envista by 63.9% during the 4th quarter. KBC Group NV now owns 7,903 shares of the company's stock valued at $152,000 after buying an additional 3,082 shares during the period. Finally, Hantz Financial Services Inc. increased its stake in Envista by 146.6% during the 4th quarter. Hantz Financial Services Inc. now owns 110,489 shares of the company's stock valued at $2,131,000 after buying an additional 65,679 shares during the period.

Analysts Set New Price Targets

Several research firms have commented on NVST. Robert W. Baird set a $21.00 target price on shares of Envista in a research note on Friday, May 2nd. New Street Research set a $19.00 target price on Envista in a report on Thursday, March 6th. Wells Fargo & Company set a $19.00 target price on Envista in a report on Saturday, March 8th. Morgan Stanley set a $16.00 target price on Envista in a report on Tuesday, April 15th. Finally, Needham & Company LLC reissued a "hold" rating on shares of Envista in a report on Thursday, March 6th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $20.08.

Envista Trading Up 0.6%

NYSE NVST traded up $0.11 on Tuesday, hitting $17.81. 2,786,657 shares of the company were exchanged, compared to its average volume of 2,549,102. The company's 50 day moving average price is $16.54 and its 200-day moving average price is $18.93. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.04 and a quick ratio of 1.76. The firm has a market capitalization of $3.02 billion, a P/E ratio of -2.74, a price-to-earnings-growth ratio of 1.27 and a beta of 0.97. Envista Holdings Co. has a twelve month low of $14.22 and a twelve month high of $23.00.

Envista (NYSE:NVST - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The company reported $0.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.20 by $0.04. The firm had revenue of $616.90 million for the quarter, compared to the consensus estimate of $608.17 million. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. The business's revenue for the quarter was down 1.1% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.26 EPS. Analysts predict that Envista Holdings Co. will post 1 earnings per share for the current fiscal year.

Envista Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.